Le presentamos resumen de:
The Lancet Oncology Published Online: 27 October 2015
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial
Takehito Shukuya, MD,Prof Takeharu Yamanaka, PhD,Takashi Seto, MD, Haruko Daga, MD,Koichi Goto, MD, Hideo Saka, MD, Dr Prof Nobuyuki Yamamoto, MD nbyamamo@wakayama-med.ac.jp
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial
Filed under Sin categoría by on . 
Leave a Comment